Rua receives narcotic license through Nimbus Health for distribution and marketing of our first product for Germany
Rua Bioscience Limited announced today that it has received its narcotic license through Nimbus Health GmbH for distribution and marketing of its first product for the German medicinal cannabis market – a move understood to make Rua the first medicinal cannabis company from New Zealand to take such a step.
Pharmaceutical Giant Acquires German Distributor Nimbus Health
Rua Bioscience is pleased to share the news that multi-national pharmaceutical company Dr Reddy's Laboratories Ltd today announced it has entered into a definitive agreement to acquire Nimbus Health. Rua Bioscience was the first New Zealand company to announce a binding export agreement with the reputable distributor in Germany and is Nimbus Health's exclusive New Zealand supplier of medicinal cannabis products.